The Economics of Biotechnology Regulation

David Zilberman

Chapter Chapter 12 in Regulating Agricultural Biotechnology: Economics and Policy, 2006, pp 243-261 from Springer

Abstract: Abstract Rational regulations of transgenic products should compare their risks and benefits with the risks and benefits of alternatives. The current regulations ignore the alternatives. Political-economic considerations govern the establishment of regulatory requirements and tend to lead to overregulation. Optimal testing should balance the gains and costs of ex ante testing and ex post monitoring. Emphasis on ex ante testing to control bad products may lead to welfare losses. The ex ante testing of new transgenic products should occur mostly at the trait level. Registration requirements at the varietal level, and even the crop level, may be very costly.

Keywords: political economy; risk; overregulation; registration; monitoring (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations: View citations in EconPapers (20)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:nrmchp:978-0-387-36953-2_12

Ordering information: This item can be ordered from
http://www.springer.com/9780387369532

DOI: 10.1007/978-0-387-36953-2_12

Access Statistics for this chapter

More chapters in Natural Resource Management and Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().